U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Balk E, Chung M, Chew P, et al. Effects of Soy on Health Outcomes. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Aug. (Evidence Reports/Technology Assessments, No. 126.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Effects of Soy on Health Outcomes

Effects of Soy on Health Outcomes.

Show details

Abbreviations

AbbreviationDescription
Quality Score: AGood quality study, least susceptible to bias. See Chapter 2, Methods.
Quality Score: BFair quality study, more susceptible to bias. See Chapter 2, Methods.
Quality Score: CPoor quality study, most susceptible to bias. See Chapter 2, Methods.
Image er-soyfu3.jpg
Broadly applicable study (referable to population category)
Image er-soyfu2.jpg
Moderately applicable study (referable to population category)
Image er-soyfu1.jpg
Narrowly applicable study (referable to population category)
Women (all)
Men
5-OHmdU5-Hydroxymethyl-2'-deoxyuridine
apo(a)Apolipoprotein(a)
apoB-100Apolipoprotein B-100
AHRQAgency for Healthcare Research and Quality
ASVDAtherosclerotic vascular disease
bAPBone-specific alkaline phosphatase (serum)
BMCBone mineral content
BMDBone mineral density
BPBlood pressure
Breast CAHistory of breast cancer
CABCommonwealth Agricultural Bureau (database)
CIConfidence Interval
CKDChronic kidney disease
CRPC-reactive protein
CTxC-telopeptide
CVDCardiovascular disease
dDays
DCDigit cancellation
DHEADehydroepiandrosterone
DHEASDehydroepiandrosterone sulfate
DHTDihydrotestosterone
DMDiabetes mellitus
D-pyrDeoxypyridinoline (urinary)
E2Estradiol
EPCEvidence-based Practice Center
FDAFood and Drug Administration
FSHFollicle stimulating hormone
FTIFree thyroxine index
GIGastrointestinal
HDLHigh density lipoprotein
HPHydroxyproline (urinary)
hs-CRPHigh sensitivity CRP
HTNHypertension
IGFInsulin-like growth factor
IGFBP-3Insulin-like growth factor binding protein-3
IsoIsoflavones
ISPIsolated soy protein
LDLLow density lipoprotein
LHLuteinizing hormone
Lp(a)Lipoprotein (a)
moMonth(s)
NNumber of subjects
NCCAMNational Center for Complementary and Alternative Medicine
NCINational Cancer Institute
ndNo data
NF-κBNuclear factor-κB
NIHNational Institutes of Health
NRCTNon-randomized controlled trial
NSNon-significant
NTxCollagen type I cross linked N-telopeptide (urinary)
OCOsteocalcin (serum)
P within P value of within-cohort change
P btw Soy P value of difference in effect between soy treatments
P vs Control P value of effect compared to control (net change)
PDGFPlatelet-derived growth factor
peri♀Peri-menopausal women
post♀Post-menopausal women
pre♀Pre-menopausal women
PSAProstate specific antigen
PTHParathyroid hormone
PTIProtein Technology Institute, Inc
PyrPyridinoline (urinary)
RCTRandomized controlled trial (parallel design)
SEStandard error
SHBGSex hormone-binding globulin
tText only, no data reported
T maxTime of maximal concentration
T.IsoflavTotal isoflavones
T3Triiodothyronine
T4Thyroxine
TBARsThiobarbituric acid reactive substances
TBGThyroid binding globulin
TEPTechnical expert panel
TgTriglycerides
TSHThyroid stimulating hormone
Tufts-NEMCTufts-New England Medical Center
UIUnique Identifier (from MEDLINE, Used when multiple studies have the same first author and year)
w/With
w/oWithout
WHOWorld Health Organization
wkWeeks
XoverCross-over studies (randomized)
yrYear(s)

Views

  • PubReader
  • Print View
  • Cite this Page

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...